Baseline HC2/COBAS | Round 1 (Baseline + 12 months follow-up) | Round 2 (24 months) | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytology | N | Colpo Referred/Completed | CIN2 | CIN3+ | Cytology | N | Colpo Referred/Completed | CIN2 | CIN3+ | |||||
N | Ratea (95 % CI) | N | Ratea (95 % CI) | N | Ratea (95 % CI) | N | Ratea (95 % CI) | |||||||
Pos/Pos | UNSAT | 1 | 1/1 | UNSAT | 1 | 0/0 | ||||||||
NILM | 260 | 152/143 | 22 | 16 | NILM | 208 | 0/0 | |||||||
ASCUS | 35 | 35/33 | 6 | 2 | ASCUS | 4 | 3/3 | |||||||
LSIL | 68 | 68/63 | 9 | 4 | LSIL | 6 | 6/6 | |||||||
ASCH | 18 | 18/15 | 4 | 5 | ASCH | 2 | 2/2 | |||||||
HSIL | 28 | 28/25 | 7 | 13 | HSIL | 1 | 1/1 | |||||||
Total | 410 | 302/280 | 48 | 7.8 (5.6 – 10.0) | 40 | 6.5 (4.5 – 8.5) | Total | 222 | 13/13 | 0 | – | 0 | – | |
Pos/Neg | UNSAT | 0 | 0/0 | UNSAT | 1 | 0/0 | ||||||||
NILM | 81 | 27/23 | 4 | NILM | 75 | 0/0 | ||||||||
ASCUS | 10 | 10/9 | 1 | ASCUS | 2 | 1/1 | ||||||||
LSIL | 13 | 13/12 | LSIL | 4 | 4/4 | |||||||||
ASCH | 2 | 2/2 | 1 | ASCH | 0 | 0/0 | ||||||||
HSIL | 0 | 0/0 | HSIL | 0 | 0/0 | |||||||||
Total | 106 | 52/46 | 5b | 0.8 (0.1 – 1.5) | 1c | 0.2 (0.0 – 0.5) | Total | 82 | 5/5 | 0 | – | 0 | – | |
Neg/Pos | UNSAT | 3 | UNSAT | 1 | 0/0 | |||||||||
NILM | 123 | NILM | 117 | 0/0 | ||||||||||
ASCUS | 1 | ASCUS | 0 | 0/0 | ||||||||||
LSIL | 5 | LSIL | 2 | 2/2 | ||||||||||
ASCH | 0 | ASCH | 0 | 0/0 | ||||||||||
HSIL | 0 | HSIL | 1 | 1/1 | 1 | |||||||||
Total | 132 | Total | 121 | 3/3 | 1d | 0.2 (0.0 – 0.5) | 0 | - | ||||||
Neg/Neg | UNSAT | 12 | UNSAT | 24 | 6/5 | |||||||||
Not done | 4901 | |||||||||||||
NILM | 585 | NILM | 4957 | 1/0 | ||||||||||
ASCUS | 17 | ASCUS | 31 | 2/2 | ||||||||||
Other atypia | 0 | Other atypia | 6 | 6/6 | ||||||||||
LSIL | 8 | LSIL | 38 | 38/36 | 2 | |||||||||
ASCH | 1 | ASCH | 4 | 4/4 | ||||||||||
HSIL | 0 | HSIL | 5 | 5/5 | 1 | 2 | ||||||||
Total | 5524 | Total | 5065 | 62/58 | 3e | 0.6 (0.0 – 1.3) | 2f | 0.4 (0.0 – 0.9) | ||||||
Total | 6172 | 354/326 | 53 | 8.6 (6.3 – 10.9) | 41 | 6.6 (4.6 – 8.7) | Total | 5490 | 83/79 | 4 | 0.7 (0.0 – 1.4) | 2 | 0.4 (0.0 – 0.9) |